Impact of 1-Year Supplementation with High-Rich Docosahexaenoic Acid (DHA) on Clinical Variables and Inflammatory Biomarkers in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial

Impact of 1-Year Supplementation with High-Rich Docosahexaenoic Acid (DHA) on Clinical Variables and Inflammatory Biomarkers in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial

A randomized, double-blind, and placebo-controlled study was conducted to assess the effect of dietary supplementation with high-rich docosahexaenoic acid (DHA) (Tridocosahexanoin-AOX<sup>®</sup> 70%) at 50 mg/kg/day in pediatric patients with cystic fibrosis (CF) as compared with placeb...

Full description

Bibliographic Details
Main Authors:	Roser Ayats-Vidal, Montserrat Bosque-García, Begoña Cordobilla, Oscar Asensio-De la Cruz, Miguel García-González, Susana Loureda-Pérez, Elena Fernández-López, Eva Robert-Barriocanal, Andrea Valiente-Planas, Joan Carles Domingo
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Series:	Nutrients
Subjects:	cystic fibrosis omega-3 fatty acids docosahexaenoic acid pulmonary function inflammatory biomarkers randomized controlled trial
Online Access:	https://www.mdpi.com/2072-6643/16/7/970

Similar Items

Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial
by: Roser Ayats-Vidal, et al.
Published: (2023-05-01)

Inadequate Content of Docosahexaenoic Acid (DHA) of Donor Human Milk for Feeding Preterm Infants: A Comparison with Mother’s Own Milk at Different Stages of Lactation
by: Félix Castillo, et al.
Published: (2021-04-01)

Docosahexaenoic acid (DHA), essentiality and requirements: why and how to provide supplementation
by: Alfonso Valenzuela, et al.
Published: (2006-06-01)

Erythrocyte Membrane Docosahexaenoic Acid (DHA) and Lipid Profile in Preterm Infants at Birth and Over the First Month of Life: A Comparative Study with Infants at Term
by: Félix Castillo Salinas, et al.
Published: (2022-11-01)

Antioxidant Activity and Neuroprotective Role of Docosahexaenoic Acid (DHA) Supplementation in Eye Diseases That Can Lead to Blindness: A Narrative Review
by: María Lafuente, et al.
Published: (2021-03-01)

Antioxidant and Anti-Inflammatory Effects of Oral Supplementation with a Highly-Concentrated Docosahexaenoic Acid (DHA) Triglyceride in Patients with Keratoconus: A Randomized Controlled Preliminary Study
by: Cristina Peris-Martínez, et al.
Published: (2023-03-01)

Oxidative Stress in Endurance Cycling Is Reduced Dose-Dependently after One Month of Re-Esterified DHA Supplementation
by: Lydia de Salazar, et al.
Published: (2020-11-01)

Importance of EPA and DHA Blood Levels in Brain Structure and Function
by: Clemens von Schacky
Published: (2021-03-01)

Structured Docosahexaenoic Acid (DHA) Enhances Motility and Promotes the Antioxidant Capacity of Aged <i>C. elegans</i>
by: Ignasi Mora, et al.
Published: (2023-07-01)

Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer’s Disease
by: Charleine Zussy, et al.
Published: (2022-04-01)

Effect of Docosahexaenoic Acid (DHA) on Breast Cancer Cells
by: Sun-yong Hwang, et al.
Published: (2015-12-01)

Prenatal Maternal Docosahexaenoic Acid (DHA) Supplementation and Newborn Anthropometry in India: Findings from DHANI
by: Shweta Khandelwal, et al.
Published: (2021-02-01)

Athletes Can Benefit from Increased Intake of EPA and DHA—Evaluating the Evidence
by: Maja Tomczyk, et al.
Published: (2023-11-01)

Re-esterified DHA improves ventilatory threshold 2 in competitive amateur cyclists
by: Vicente Ávila-Gandía, et al.
Published: (2020-10-01)

The role of docosahexaenoic acid in neuronal development and the importance of DHA supplementation during pregnancy
by: Aleksandra Karmańska, et al.
Published: (2023-10-01)

Derivation of the Omega-3 Index from EPA and DHA Analysis of Dried Blood Spots from Dogs and Cats
by: William S. Harris, et al.
Published: (2022-12-01)

Research Progress of Mitochondrial-Mediated Docosahexaenoic Acid (DHA) Antioxidation
by: Xiaoting SUN, et al.
Published: (2022-05-01)

Dietary Alpha-Linolenic Acid Supports High Retinal DHA Levels
by: Andrew J. Sinclair, et al.
Published: (2022-01-01)

Differential Effects of DHA- and EPA-Rich Oils on Sleep in Healthy Young Adults: A Randomized Controlled Trial
by: Michael J. Patan, et al.
Published: (2021-01-01)

Efficient Enrichment of Retinal DHA with Dietary Lysophosphatidylcholine-DHA: Potential Application for Retinopathies
by: Dhavamani Sugasini, et al.
Published: (2020-10-01)

Docosahexaenoic acid content is significantly higher in ghrita prepared by traditional Ayurvedic method
by: Kalpana S Joshi
Published: (2014-01-01)

Docosahexaenoic acid in the treatment of male infertility
by: I. V. Vinogradov, et al.
Published: (2018-12-01)

Does aging change docosahexaenoic acid homeostasis? Implications for the challenge to cognitive health in the elderly
by: Castellano Christian-Alexandre, et al.
Published: (2011-07-01)

Synthesis and Characterization of a New Bivalent Ligand Combining Caffeine and Docosahexaenoic Acid
by: Víctor Fernández-Dueñas, et al.
Published: (2017-02-01)

Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [13C]DHA in phosphatidylcholine
by: Dominique Lemaitre-Delaunay, et al.
Published: (1999-10-01)

Differentiating EPA from EPA/DHA in cardiovascular risk reduction
by: Peter P. Toth, et al.
Published: (2022-05-01)

Fish Oil Enriched in EPA, but Not in DHA, Reverses the Metabolic Syndrome and Adipocyte Dysfunction Induced by a High-Fat Diet
by: Roberta Dourado Cavalcante da Cunha de Sá, et al.
Published: (2021-02-01)

Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial
by: Rodríguez C, et al.
Published: (2019-05-01)

Complete assessment of whole-body n-3 and n-6 PUFA synthesis-secretion kinetics and DHA turnover in a rodent model
by: Adam H. Metherel, et al.
Published: (2018-02-01)

Encapsulation of docosahexaenoic acid (DHA) using self-assembling food-derived proteins for efficient biological functions
by: Yumeng Liu, et al.
Published: (2023-09-01)

EPA and DHA containing phospholipids have contrasting effects on membrane structure
by: Samuel C.R. Sherratt, et al.
Published: (2021-01-01)

Turnover of brain DHA in mice is accurately determined by tracer-free natural abundance carbon isotope ratio analysis
by: R.J. Scott Lacombe, et al.
Published: (2020-01-01)

Maternal DHA intake in mice increased DHA metabolites in the pup brain and ameliorated MeHg-induced behavioral disorder
by: Ami Oguro, et al.
Published: (2023-11-01)

Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids
by: Fraser D. Russell, et al.
Published: (2012-11-01)

The effects of Docosahexaenoic Acid (DHA) on Helicobacter pylori eradication, some serum inflammatory factors and total antioxidant capacity
by: Shahram Agah, et al.
Published: (2013-09-01)

Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA and DHA
by: Simon eDyall
Published: (2015-04-01)

Docosahexaenoic acid (DHA), an essential fatty acid for the proper functioning of neuronal cells: their role in mood disorders
by: Alfonso Valenzuela B
Published: (2009-06-01)

EPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4
by: Julie A. Eclov, et al.
Published: (2015-12-01)

Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation
by: Elisabetta Teopompi, et al.
Published: (2019-08-01)

Effects of high-dose docosahexaenoic acid supplementation as an add-on therapy for canine idiopathic epilepsy: A pilot study
by: Tomohiro Yonezawa, et al.
Published: (2023-07-01)